COMPUGEN LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.49 USD | +2.05% |
|
+33.06% | +25.00% |
| 20/05 | Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating | MT |
| 20/05 | Transcript : Compugen Ltd., Q1 2024 Earnings Call, May 20, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 22Cr | - | - | - | |||
| 6.39TCr | - | |||||
| 4.18TCr | ||||||
| 4.05TCr | ||||||
| 2.72TCr | ||||||
| 2.65TCr |
- Stock Market
- Equities
- CGEN Stock
- Charts Compugen Ltd.
- Sector Chart
